tiprankstipranks
Artelo Biosciences announces acceptance of ART26.12 into NIH PSPP program
PremiumThe FlyArtelo Biosciences announces acceptance of ART26.12 into NIH PSPP program
2M ago
Is ARTL a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARTL a Buy, Before Earnings?
2M ago
Artelo Biosciences initiated with a Buy at EF Hutton
Premium
The Fly
Artelo Biosciences initiated with a Buy at EF Hutton
3M ago
Artelo Biosciences announces presentations about ART12.11
PremiumThe FlyArtelo Biosciences announces presentations about ART12.11
6M ago
Artelo Biosciences’ FABP inhibitor platform featured in three presentations
Premium
The Fly
Artelo Biosciences’ FABP inhibitor platform featured in three presentations
6M ago
Artelo Biosciences presents preclinical data on ART26.12
Premium
The Fly
Artelo Biosciences presents preclinical data on ART26.12
6M ago
Artelo Biosciences reports 2023 EPS ($3.14), consensus ($2.56)
PremiumThe FlyArtelo Biosciences reports 2023 EPS ($3.14), consensus ($2.56)
9M ago
Artelo Biosciences Revises Stock Options for Employee Retention
Premium
Company Announcements
Artelo Biosciences Revises Stock Options for Employee Retention
10M ago
Artelo Biosciences announces publication on research on ART26.12
Premium
The Fly
Artelo Biosciences announces publication on research on ART26.12
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100